NCT07291947 PULSAR Combined With Immunotherapy and Chemotherapy Status RECRUITING Phase PHASE1/PHASE2
NCT07291063 Anti-PD-1/PD-L1 Antibodies Plus Gemcitabine and Cisplatin for Advanced CCA Status RECRUITING Phase N/A
NCT07263217 Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury Status RECRUITING Phase NA
NCT07260175 Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT07224750 A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer Status RECRUITING Phase N/A
NCT07213791 A Study of LY4337713 in Participants With FAP-Positive Solid Tumors Status RECRUITING Phase PHASE1
NCT07206355 In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers Status RECRUITING Phase N/A
NCT07161869 Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) Status NOT_YET_RECRUITING Phase N/A
NCT07155525 Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas Status RECRUITING Phase PHASE3
NCT07146646 Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer Status RECRUITING Phase PHASE2
NCT07118176 Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07106827 A Study of GV20-0251 in Advanced or Refractory Solid Tumors Status RECRUITING Phase PHASE1
NCT07105852 Exploring the Safety and Efficacy of Sacituzumab Tirumotecan Combined With Pucotenlimab in the Treatment of Advanced Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT07064447 Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator Status NOT_YET_RECRUITING Phase N/A
NCT07043387 Streamlining Radioembolization for CCC and Metastatic Liver Cancer Status RECRUITING Phase N/A
NCT07030140 Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT07025174 Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE2